About us.

Our business: a new interventional weight-loss therapy.

A team of experienced engineers and physicians is developing a medical device for a minimally invasive, outpatient, interventional treatment of obesity.  

The therapy is easy to execute without major risks or major side effects.

A prototype has been developed and successfully tested for safety and efficacy.

Several awards and prizes confirm our innovative approach.

bn
Morgan Stanley
bn
McKinsey
bn
Goldman Sachs

Our therapy.

Freezing the hunger feeling. 

We have developed a medical device for a one-time, interventional therapy. By this office-based procedure a long-term reduction of the hunger feeling will be achieved. The gastric trunks of the vagus nerve conveying the hunger feeling to the brain are disrupted by the proven technology of cryo-ablation.

2025

Two more patents filed

2025
2024

Proof of concept demonstrated and prototype successfully tested: safety and effectiveness of therapy verified – ETH Zuerich (CH) and CV Path Institute (USA)

2024
2024

Second generation of the prototype (Blizzard Catheter) is completed

2024
2023

Sedivention wins three awards from BayStartUp

2023
2022

Third patent filed

2022
2022

Prototype development is completed

2022
2021

Sedivention GmbH is founded

2021
2020

First patent granted

2020
2019

Two patents filed

2019

Awards:

Winner in all three phases of the Business Plan Competition 2023

Winner of the
Venture Cup 2023

Accelerator:

Memberships:

Grants:

Investors:

Dr.-Ing.-Andreas-Bröcker

Dr.-Ing. Andreas Bröcker

CEO
Co-Founder

Dr. med. Ute Nollert

Dr. med. Ute Nollert

CMO
Founder

André Burch EMBA

André Burch, EMBA

Co-Founder

Ann-Kathrin Waldmann

Business Development /
Business Intelligence

Jakob Wintermeyer

Corporate Fundraising /
Investor Management

Sara Nehmeier

Marketing Manager /
sedivention Platform

Scroll to Top